ZNTL
ZentalisยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ZNTL Profile
Zentalis Pharmaceuticals, Inc.
A clinical-stage biopharmaceutical company that focused on small molecule therapeutics for cancers
Biological Technology
12/23/2014
04/03/2020
NASDAQ Stock Exchange
166
12-31
Common stock
10275 Science Center Dr., Suite 200, San Diego, California 92121
--
Zentalis Pharmaceuticals, Inc., was incorporated in Delaware on December 23, 2014 as Zeno Pharmaceuticals, Inc. Zentalis Pharmaceuticals, Inc., is a clinical-stage pharmaceutical company dedicated to the discovery and development of clinically differentiated novel small molecule therapies targeting the underlying biological pathways of cancer.
